Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients
Author(s) -
Abiy Habtewold,
Wondwossen Amogne,
Eyasu Makonnen,
Getnet Yimer,
K. Riedel,
N. Ueda,
A. Worku,
Walter E. Haefeli,
Lars Lindquist,
Getachew Aderaye,
Jürgen Burhenne,
Eleni Aklillu
Publication year - 2011
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkr304
Subject(s) - efavirenz , peripheral blood mononuclear cell , ugt2b7 , pharmacology , drug , nevirapine , medicine , reverse transcriptase inhibitor , cyp2b6 , genotype , lamivudine , immunology , virology , pharmacokinetics , human immunodeficiency virus (hiv) , viral load , biology , antiretroviral therapy , cyp3a4 , in vitro , genetics , metabolism , glucuronidation , cytochrome p450 , gene , microsome , hepatitis b virus , virus
We investigated the long-term effect of efavirenz autoinduction on its plasma/peripheral blood mononuclear cell (PBMC) exposure and the CD4 count, and the importance of sex and pharmacogenetic variations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom